candidates for glp-1 Are You a Good Candidate Weight Loss Treatment? S-1/A

These SCFAs can stimulate cellular activity in the gut to release GLP-1. Fast-track GLP-1 Production from Within Ready to naturally fast-track GLP-1 production

Understanding why provider guidance matters helps patients access these medications responsibly through appropriate channels

Currently used antidepressant drugs, which mostly target brain monoaminergic neurotransmission, have limited clinical efficacy

Hypoglycemia risk increases when these strategies are combined with sulfonylureas or insulin, requiring close monitoring and medication adjustment

Youtheory has launched a new doctor-formulated product line that includes myHMB designed to support GLP-1 users.

Read highlights from the released 2025 Standards of Care, including recommendations for CGM use in type 2 diabetes for the first time, the use of GLP-1 drugs for kidney and heart benefits and a warning of DKA risk in recreational marijuana use.